Sign inGet started

ADAMS JULIAN

Insider CIK 1230486 · INFI President of R&D · PIRS Director · GMDA Chief Executive Officer, Director · ELTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ELTX Elicio Therapeutics, Inc. A Award deriv2026-08-312026-09-0221,750— $021,750SEC↗
ELTX Elicio Therapeutics, Inc. A Award deriv2026-08-312026-09-0221,750— $021,750SEC↗
ELTX Elicio Therapeutics, Inc. A Award deriv2025-05-192025-05-207,900— $07,900SEC↗
ELTX Elicio Therapeutics, Inc. A Award deriv2024-11-212024-11-254,100— $04,100SEC↗
GMDA Gamida Cell Ltd. A Award2024-01-312024-02-02200,000— $0423,750SEC↗
ELTX Elicio Therapeutics, Inc. A Award deriv2023-12-282023-12-294,100— $04,100SEC↗
GMDA Gamida Cell Ltd. A Award deriv2023-10-192023-10-2056,600— $056,600SEC↗
GMDA Gamida Cell Ltd. A Award2023-10-192023-10-2028,300— $0223,750SEC↗
GMDA Gamida Cell Ltd. A Award deriv2023-02-082023-02-1056,600— $056,600SEC↗
GMDA Gamida Cell Ltd. A Award2023-02-082023-02-1028,300— $0223,750SEC↗
GMDA Gamida Cell Ltd. A Award deriv2022-11-182022-11-229,500— $09,500SEC↗
GMDA Gamida Cell Ltd. A Award2022-11-182022-11-222,000— $0195,450SEC↗
GMDA Gamida Cell Ltd. A Award deriv2022-07-272022-08-10291,100— $0291,100SEC↗
GMDA Gamida Cell Ltd. A Award2022-07-272022-08-1048,500— $0124,650SEC↗
GMDA Gamida Cell Ltd. A Award2022-07-272022-08-1068,800— $0193,450SEC↗
PIRS PIERIS PHARMACEUTICALS, IN A Award deriv2018-01-252018-01-2920,000— $020,000SEC↗
PIRS PIERIS PHARMACEUTICALS, IN A Award deriv2017-01-252017-01-3020,000— $020,000SEC↗
INFI INFINITY PHARMACEUTICALS, A Award2016-10-312016-11-0259,150— $059,150SEC↗
PIRS PIERIS PHARMACEUTICALS, IN A Award deriv2016-07-252016-07-2630,000— $030,000SEC↗
INFI INFINITY PHARMACEUTICALS, A Award deriv2016-01-062016-01-0880,000— $080,000SEC↗
INFI INFINITY PHARMACEUTICALS, A Award deriv2015-01-142015-01-16125,000— $0125,000SEC↗
INFI INFINITY PHARMACEUTICALS, A Award deriv2014-01-102014-01-1456,900— $056,900SEC↗
INFI INFINITY PHARMACEUTICALS, A Award deriv2013-01-042013-01-08101,780— $0101,780SEC↗
INFI INFINITY PHARMACEUTICALS, A Award deriv2012-01-062012-01-09126,850— $0126,850SEC↗